Navigation Links
Ampio Pharmaceuticals Announces Exercise of Over-Allotment Option
Date:7/13/2012

GREENWOOD VILLAGE, Colo., July 13, 2012 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (Nasdaq: AMPE), a biopharmaceutical company conducting clinical trials on its three lead drugs (Ampion™, Optina™ & Zertane™), licensing distribution of these drugs and developing additional new drugs, today announced the exercise in full of the over-allotment option granted to the underwriters by Ampio and certain of its stockholders with respect to the purchase of 692,310 shares of common stock at a public offering price of $3.25 per share.  The over-allotment option is being exercised in connection with Ampio's previously announced underwritten public offering of 4,615,400 shares of common stock, which was subsequently increased by 181,250 shares to an aggregate of 4,796,650 such shares.  As a result of the exercise of the over-allotment option and the additional 181,250 shares of common stock purchased in the previously announced public offering, the total gross proceeds to Ampio from the offering will be approximately $16,912,545, before deducting the underwriting discount and other estimated offering expenses.

(Logo: http://photos.prnewswire.com/prnh/20120516/MM09116LOGO)

Aegis Capital Corp. and Fordham Financial Management, Inc. are acting as joint book-running managers for the offering.

The offering is being made pursuant to a shelf registration statement that Ampio filed with the Securities and Exchange Commission ("SEC") and is effective.  A preliminary prospectus supplement and accompanying base prospectus relating to the offering were filed with the SEC and a final prospectus supplement and accompanying base prospectus will be filed with the SEC.  When available, copies of the final prospectus supplement and accompanying base prospectus relating to the offer
'/>"/>

SOURCE Ampio Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Ampio Pharmaceuticals Announces Pricing of Public Offering of 4,615,400 Shares of Common Stock
2. Ampio Pharmaceuticals Announces Proposed Public Offering
3. Ampios CEO and CSO Send Message to Shareholders
4. Four-Time Triathlon World Champion Melanie McQuaid Selects Polar USA as Official Heart Rate Training Solution
5. Ampio Pharmaceuticals Schedules 2012 Update Webcast
6. Four Californians Selected As Breakaway from Cancer® Champions To Be Honored During Amgen Tour of California
7. Ampio Awarded US and Canadian Patents that will Bolster the Commercialization of Optina™ for the treatment of Diabetic Macular Edema (DME)
8. Par Formulations (Formerly Edict Pharmaceuticals) Receives First ANDA Approval
9. ResearchMoz.US: Direct to Consumer (DTC) Advertising in Pharmaceuticals - Shift From Traditional Mass-Media Platforms Towards Personalization via Online and Social Media- Market Research Report
10. Cumberland Pharmaceuticals To Announce Second Quarter 2012 Financial Results On August 2, 2012
11. Optimer Pharmaceuticals to Host Conference Call and Webcast to Discuss Second Quarter 2012 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014 Massachusetts General Hospital (MGH), the Broad ... announced today that they have launched a strategic ... targets and develop novel therapies for inflammatory bowel ... worldwide. The MGH-Broad-Amgen collaboration brings together scientists with ...
(Date:1/15/2014)... January 15, 2014 BreedIT Corp (OTC: ... worldwide distributor of highly sophisticated agro-breeding solutions for plant ... 2014, the Company,s board of directors appointed chemistry and ... its new member of the board. From ...
(Date:1/15/2014)... Jan. 15, 2014 Tegra Medical is very pleased to ... as its new Chief Executive Officer.  Mark was promoted from ... has overseen the company,s four facilities in Massachusetts ... Mr. King joined Tegra Medical in 2012 with 20+ years ...
Breaking Medicine Technology:Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 4BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 3Tegra Medical Appoints New Chief Executive Officer 2Tegra Medical Appoints New Chief Executive Officer 3
... Part D beneficiaries who enter the "donut hole," where ... prescription costs, are twice as likely to discontinue  their ... or generic medications, a new study published today in ... The study conducted by researchers from Harvard ...
... Aug. 16, 2011 BD (Becton, Dickinson and Company) ... technology company, today announced the completion of its acquisition ... the PhaSeal® System, the leading closed-system drug transfer device ... packaged in vials.  The acquisition expands the scope of ...
Cached Medicine Technology:CVS Caremark, Harvard and Brigham and Women's Researchers Say Medicare 'Donut Hole' Can Lead to a Decrease in Medication Adherence 2CVS Caremark, Harvard and Brigham and Women's Researchers Say Medicare 'Donut Hole' Can Lead to a Decrease in Medication Adherence 3BD Completes Acquisition of Carmel Pharma 2BD Completes Acquisition of Carmel Pharma 3
(Date:7/9/2014)... OH, July 10, 2014 -- The World Health Organization ... minutes of moderate to vigorous physical activity (MVPA) each ... of their MVPA during school hours. Therefore, it ... hours would increase MVPA. In a new study ... , researchers confirmed that time spent outdoors after school ...
(Date:7/9/2014)... Perelman School of Medicine at the University of Pennsylvania ... received an $8 million grant from the National Cancer ... therapy (PDT) in patients with malignant pleural mesothelioma, a ... itself in the lining of the lungs and is ... will fund a clinical trial and additional studies looking ...
(Date:7/9/2014)... researchers have uncovered mutations in a cell-signaling pathway that ... may expand treatments for patients because drugs targeting some ... in clinical trials. , Reporting July 9 in ... including researchers at Washington University School of Medicine in ... tumors from 230 patients with lung adenocarcinoma. , "This ...
(Date:7/9/2014)... drug users in Russia might contribute to HIV ... conducted by researchers from Boston University Schools of ... Petersburg Pavlov State University, sought to discover the ... of a cohort of HIV-positive people with lifetime ... arrested by police were more likely to share ...
(Date:7/9/2014)... DALLAS July 9, 2014 There has been ... at UT Southwestern Medical Center using MyChart, the online, ... radiology results, communicate with their healthcare providers, schedule appointments, ... number of patients actively using MyChart each ... each year increased more than 10-fold, according to a ...
Breaking Medicine News(10 mins):Health News:Go play outside! Outdoor time promotes physical activity in youth 2Health News:Penn mesothelioma program receives $8 million NCI grant 2Health News:Lung cancer study hints at new treatments 2Health News:BU researchers relate arrests with HIV risk environment 2Health News:MyChart use skyrocketing among cancer patients, UT Southwestern study finds 2Health News:MyChart use skyrocketing among cancer patients, UT Southwestern study finds 3
... conducted by the American Institute for Cancer Research (AICR), ... cells, secreting hormones and other growth factors into the ... the popular belief that fat is an inert substance. ... levels of these hormones and growth factors play a ...
... patients coming to Queensland Public hospital will receive free ... to quit smoking. This free nicotine replacement program will ... which is one of the leading cause of preventable ... the systems from head to foot. Cigarette smoke contains ...
... Professor Geetanjali Dabral Datta and her research team from ... disparities occur in cervical cancer screening for women.// Cervical ... which proves to be a very useful and sensitive ... cervical cancer is easily curable compared to late stage ...
... that cold and flu drugs containing pseudoephedrine will be banned ... limit illegal manufacturing of such drugs. // ,This new ... in Queensland. Pharmacists have been asked to ensure that unknown ... out if their need is genuine. Pseudoephedrine is often used ...
... that every patient referral from a GP in England would ... end // of this month. ,But ministers have admitted ... are available - barely 2.7 per cent of referrals were ... that between October 2004 and September 2005, about 9.9 million ...
... or benefit analysis it has been found that unless heart ... farmed salmon // . ,The reasoning put forth is ... acids it also has a large amount of chemical contaminants. ... of cancer, memory impairment and neurobehavioral changes in children. ...
Cached Medicine News:Health News:GP's online referral scheme in UK 'a national IT disaster' 2
... Portex® ULTRAperc® Percutaneous Dilation Tracheostomy ... of a tracheostomy tube using ... by means of a single-stage ... with or without the Portex® ...
... features a patented Per-fit™ flexible PVC tube ... low-profile cuff specifically designed to reduce insertion ... patients anatomy. The kit s unique obturator/dilator ... snugly, allowing for an easier transition through ...
... Each kit features a patented Per-fit™ flexible ... and a low-profile cuff specifically designed to ... to the patients anatomy. The kit s ... the tube snugly, allowing for an easier ...
... Self-contained kits provide convenience and cost ... tracheostomy care trays offer a variety of ... and management of the tracheostomized patient. , ... trays, and trays with disposable inner cannula ...
Medicine Products: